Award details

The synthesis and pharmacology of subtype- selective ligands for neuronal nicotinic receptors

ReferenceB12081
Principal Investigator / Supervisor Professor Timothy Gallagher
Co-Investigators /
Co-Supervisors
Ms Sue Wonnacott
Institution University of Bristol
DepartmentChemistry
Funding typeResearch
Value (£) 154,669
StatusCompleted
TypeResearch Grant
Start date 01/01/2000
End date 01/01/2003
Duration36 months

Abstract

This collaborative study, based on UB-165, a novel, enantiospecific subtype- selective nicotinic agonist, aims to define individual pharmacophores for neuronal nicotinic receptor (nAChR) subtypes, and to use the ligands to characterise native nAChR. A series of structural analogues of UB-165, as well as new classes of ligands, will be generated by efficient chemical synthesis. All ligands will be characterised pharmacologically at defined nAChR subtypes, and used to distinguish presynaptic subtypes in the brain. These results will direct ligand design, generating informative structure-activity relationships and the evolution of new, more critical pharmacophore models that will be significant for rational drug design targeted at these sites. (Joint with award B11785.)

Summary

unavailable
Committee Closed Committee - Biomolecular Sciences (BMS)
Research TopicsX – not assigned to a current Research Topic
Research PriorityX – Research Priority information not available
Research Initiative X - not in an Initiative
Funding SchemeX – not Funded via a specific Funding Scheme
terms and conditions of use (opens in new window)
export PDF file